COVID-19 Clinical Trial
Official title:
Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges
Verified date | March 2023 |
Source | Bitlis Eren University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.
Status | Completed |
Enrollment | 57 |
Est. completion date | September 7, 2022 |
Est. primary completion date | August 5, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - COVID-19 patients in the subacute period discharged - Be 18 years or older - Having received oxygen therapy or mechanical ventilation support in the hospital - Access to online interviews and web-based exercises with a secure internet connection - Having sufficient speaking and hearing skills for telerehabilitation - Volunteer to participate in research Exclusion Criteria: - Unstable clinical condition - Having had cerebrovascular disease, intra-articular drug injection or surgery of the lower extremities in the last 6 months - Inability to walk independently, even with an assistive device - Having serious neuromuscular problems - Not being cooperative enough to answer and understand questionnaires and scales |
Country | Name | City | State |
---|---|---|---|
Turkey | Marmara University | Maltepe | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Bitlis Eren University | Marmara University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Oxygen Saturation and Heart Rate | Participants' resting oxygen saturation and heart rate, and oxygen saturation and heart rate after the tests will be evaluated | Change from baseline oxygen saturation (SaO2) and heart rate (beats per minute) of the patients at the end of the 8th week and, postintervation sixth months | |
Other | Dyspnea and Fatigue Level | Participants' dyspnea and fatigue level, and dyspnea and fatigue level after the tests will be evaluated according to the Modified Borg (0-10) scale | Change from baseline dyspnea and fatigue of the patients at the end of the 8th week and, postintervation sixth months | |
Other | Timed Up-Go Test (TUG) | Participants are asked to get up from the chair, walk 3 m at a comfortable and safe pace, return and sit back in the chair. | Change from baseline time (second) of the patients at the end of the 8th week and, postintervation sixth months | |
Other | International Physical Activity Questionnaire Short Form (IPAQ) | It is a scale used to determine the level of physical activity in adults. The scale questions vigorous and moderate physical activity, walking time of at least 10 minutes and daily sitting time in the last 7 days. | Change from baseline metabolic equivalent (MET)-minute/week of the patients at the end of the 8th week and, postintervation sixth months | |
Other | Hospital Anxiety Depression (HAD) Scale | The questionnaire, which was filled in by the patient and includes the anxiety and depression subscales, consists of 14 items. Responses are scored between 0-3. | Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months | |
Other | Fatigue Severity Scale | This scale is a 9-item scale that measures the severity of fatigue in patients and its effect on one's activities and lifestyle. Responses are scored on a seven-point scale with 1 = strongly disagree and 7 = strongly agree. | Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months | |
Other | Quality of Life Scale: Short Form-36 (SF-36) | The self-assessment scale consists of 36 items and 8 sub-dimensions. The scale is evaluated considering the last four weeks. On the scale, 0 points indicate poor health and 100 points indicate good health. | Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months | |
Primary | Incremental Shuttle Walk Test (ISWT) | The participant will be asked to walk around two 9-meter cones and complete them within the given time. Oxygen saturation and heart rate will be measured before and immediately after the test. They will be asked to self-report dyspnea and fatigue according to the modified Borg scale (0-10). | Change from baseline walking distance (meters) of the patients at the end of the 8th week and, postintervation sixth months | |
Secondary | 30-Second Chair Stand Test (30 CST) | The patient will be asked to sit and stand as much as possible within 30 seconds, with his hands crossed over his chest. The number of sitting and staying for 30 seconds will be noted. | Change from baseline number of sitting and staying of the patients at the end of the 8th week and, postintervation sixth months | |
Secondary | Brief Physical Performance Battery (BPPB) | It is a test used to evaluate the lower extremity function of patients. This battery represents the sum of 3 functional tests such as standing stance tests, 4 meters walking test and 5 times chair sit and stand (5STS). Each test is scored between 0 (not completing the test) and 4 (highest performance level) | Change from baseline score of the patients at the end of the 8th week and, postintervation sixth months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|